Becton, Dickinson and Company Stock Outlook: Is Wall Street Bullish or Bearish?

With a market cap of $64.3 billion, Becton, Dickinson and Company (BDX) is a global medical technology firm developing and selling medical devices, laboratory equipment, and diagnostic products. The Franklin Lakes, New Jersey-based company operates through three segments: BD Medical; BD Life Sciences; and BD Interventional, serving healthcare providers and researchers worldwide.

Shares of the medical device manufacturer have underperformed the broader market over the past 52 weeks. BDX has decreased 4.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 30.1%. In 2024, BDX stock declined 8.8%, compared to SPX's 24.1% YTD gain.